These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7395293)

  • 1. [Clinical chemistry parameters in continuous peritoneal dialysis].
    Jung N; Karátson A; Thieler H; Baufeld A; Schmidt U
    Z Gesamte Inn Med; 1980 Feb; 35(3):123-6. PubMed ID: 7395293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
    Thomson NM; Walker RG; Whiteside G; Scott DF; Atkins RC
    Proc Eur Dial Transplant Assoc; 1979; 16():171-7. PubMed ID: 548978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglucose dialysis solution induces changes in blood chemistry.
    Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
    Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic ambulatory peritoneal dialysis].
    Glasson P; Leski M; Favre H
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1232-8. PubMed ID: 7025196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.
    Gao H; Lew SQ; Bosch JP
    Clin Nephrol; 1998 Dec; 50(6):375-80. PubMed ID: 9877111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with nocturnal intermittent peritoneal dialysis].
    Brunkhorst R; Wrenger E; Koch KM
    Dtsch Med Wochenschr; 1993 Jan; 118(1-2):6-12. PubMed ID: 8420776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.
    Rojas-Campos E; Alcántar-Medina M; Cortés-Sanabria L; Martínez-Ramírez HR; Camarena JL; Chávez S; Flores A; Nieves JJ; Monteón F; Gómez-Navarro B; Cueto-Manzano AM
    Rev Invest Clin; 2007; 59(3):184-91. PubMed ID: 17910410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Semi-continuous peritoneal dialysis - an advantageous modification of the peritoneal dialysis technic].
    Kleint V; Stradtmann H; Klinger H; Palm B; Frenkel I
    Z Urol Nephrol; 1981 Apr; 74(4):299-304. PubMed ID: 7269815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting low values of serum albumin in CAPD patients.
    Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
    Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged survival with weekly peritoneal dialysis in chronic uremic patients].
    Treviño Becerra A; Jauregui Ontiveros B
    Prensa Med Mex; 1978; 43(11-12):302-7. PubMed ID: 757607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.